
|Articles|January 28, 2010
supplement promo
In this January 2010 supplement to Oncology, guest editor Axel Grothey from the Mayo Clinic, explores adjuvant therapy considerations in stage II colon cancer.
Advertisement
In this January 2010 supplement to Oncology, guest editor Axel Grothey from the Mayo Clinic, explores adjuvant therapy considerations in stage II colon cancer.
This supplement and associated publication costs were funded by Genomic Health.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Autologous Stem Cell Transplantation in Multiple Myeloma: Is It Still the Gold Standard?
2
FDA Approves Pembrolizumab/Chemo in Platinum-Resistant GYN Indications
3
Top 5 Surgical Takeaways from NCCN Breast for Invasive Breast Cancer
4
Nivolumab Sustains 9-Year Survival Benefit in Resected Stage III/IV Melanoma
5







































